IGM Faculty

Institute for Genomic Medicine Faculty

Senior Leadership

Richard K. Wilson, PhD
Executive Director

Elaine R. Mardis, PhD
Co-Executive Director

Julie M. Gastier-Foster, PhD, FACMG
Senior Director

Peter White, PhD
Senior Director

Elena Chiappinelli, MSH, MHA
Administrative Director

Research Faculty

Daniel C. Koboldt, MS
Vincent J. Magrini, PhD

Clinical Directors

Maria Alfaro, PhD, FACMG
Catherine E. Cottrell, PhD, FACMG
Ruthann B. Pfau, PhD, FACMG
Shalini C. Reshmi, PhD, FACMG
Erik J. Zmuda, PhD

Managers

Yvonne Moyer, MBA, SH(ASCP)
Vijay Nadella, MS
Laura Starkey, MBA, MT(ASCP)SBB

Genetic Counselors

Sayaka Hashimoto, MS, LGC
Theodora Jacobson Matthews, MS, LGC
Theresa Mihalic Mosher, MS, LGC
Danielle E. Mouhlas, MS, LGC
Elizabeth A. Varga, MS, LGC

Fellows

Matthew R. Avenarius, PhD
Elizabeth S. Barrie, PhD
Stephanie LaHaye, PhD
Cecelia R. Miller, PhD
Katherine Miller, PhD

Richard Wilson, PhD and Elaine Mardis, PhD

Dr. Wilson and Dr. Mardis joined Nationwide Children's Hospital as executive director and co-executive director of the Institute for Genomic Medicine in October 2016.

Collectively, they have played key roles in notable federally funded genomics research initiatives, including the Human Genome Project, The Cancer Genome Atlas, the Human Microbiome Project and the 1,000 Genomes Project.

Richard Wilson

Richard Wilson, PhD
Dr. Wilson was named the world's most cited researcher in 2013 by Thomson Reuters' ScienceWatch with 15 significantly cited papers. Among numerous honors, awards and notable positions, he is a fellow of the American Association for the Advancement of Science (AAAS), a member of the International Cancer Genomics Consortium, and former co-chair of the executive committee for The Cancer Genome Atlas of the National Cancer Institute, where he remains a member of the Steering Committee.

Elaine Mardis

Elaine Mardis, PhD
Dr. Mardis is an internationally recognized expert in cancer genomics who received the 2016 Morton K. Schwartz award from the American Association for Clinical Chemistry. She also was included on the 2013 Thomson Reuters' list of most cited researchers, one of only two women listed. Among her several prominent roles, Dr. Mardis is a member of the Board of Directors for the American Association for Cancer Research and a member of the Supervisory Board of Qiagen N.V. She is editor-in-chief of Molecular Case Studies and an associate editor of Molecular Cancer ResearchDisease Models and Mechanisms and Annals of Oncology. In 2013 she was featured in Discover magazine's "The Year in Science." In 2017 she will be awarded the Luminary Award from the Precision Medicine World Conference.

 

Previously Drs. Wilson and Mardis led the McDonnell Genome Institute at Washington University, as one of only four genomics centers funded by the National Human Genome Research Institute. In 2008, their team became the first to use new DNA sequencing technology to compare the tumor DNA of a cancer patient with that same patient's normal tissue DNA, demonstrating that genetic differences between tumor and normal gene sequences could identify mutations driving cancer growth. This foundational work resulted in an international effort to decode cancer genomes and unlock their secrets to improve treatments and outcomes.

Their foundational contributions to discovery research in pediatric genomics have been significant. Drs. Wilson and Mardis co-led the Pediatric Cancer Genome Project, which sequenced the genomes of more than 750 children with some of the most devastating cancers.